Serum levels of bone cytokines are increased in indolent systemic mastocytosis associated with osteopenia or osteoporosis - 30/10/13
Doi : 10.1016/j.jaci.2013.06.019
Anja Rabenhorst, PhD a, Bastian Christopeit, MD a, Silke Leja, MTA a, Alexander Gerbaulet, PhD b, Svea Kleiner, MSc c, Anja Förster, MSc a, Ulrike Raap, MD c, Claudia Wickenhauser, MD d, Karin Hartmann, MD a 
a Department of Dermatology, University of Cologne, Cologne, Germany
b Institute for Immunology, University of Technology Dresden, Medical Faculty Carl-Gustav Carus, Dresden, Germany
c Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany
d Institute of Pathology, University of Leipzig, Leipzig, Germany
| This work was supported by research grants from the German Research Council (DFG; CRC/SFB832, project A14), the German-Israeli Foundation for Scientific Research and Development (993/2008), and the Wilhelm Sander Foundation (1999.049.2) to K.H. |
|
| Disclosure of potential conflict of interest: K. Hartmann is a consultant in a Novartis clinical trial on mastocytosis; is (or recently was) a speaker for ALK-Abelló, Novartis, and Shire; and received research grants from Novartis. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2013
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 132 - N° 5
P. 1234 - novembre 2013 Retour au numéro
Article précédent
- Racial comparison of filaggrin null mutations in asthmatic patients with atopic dermatitis in a US population
- Jackie P.-D. Garrett, Ole Hoffstad, Andrea J. Apter, David J. Margolis
- Interaction between atopy and blood eosinophils in the development of childhood wheeze
- Jon Genuneit
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?